« Back to Record
Citation APA

Kendler, D., Marin, F., Zerbini, C., Russo, L., Greenspan, S., Zikan, V., Bagur, A., Malouf-Sierra, J., Lakatos, P., Fahrleitner-Pammer, A., Lespessailles, E., Minisola, S., Body, J.-J., Geusens, P. P. M. M. P., Möricke, R., & López-Romero, P. (2018). Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet, 392(10162), 2352. doi:10.1016/S0140-6736(17)32137-2


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/296991

Kendler, D., Marin, F., Zerbini, C., Russo, L., Greenspan, S., Zikan, V., Bagur, A., Malouf-Sierra, J., Lakatos, P., Fahrleitner-Pammer, A., Lespessailles, E., Minisola, S., Body, J.-J., Geusens, P. P. M. M. P., Möricke, R., & López-Romero, P. (2018). Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial. Lancet, 392(10162), 2352. doi:10.1016/S0140-6736(17)32137-2